These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 10918401

  • 1. Outcome of T cell-depleted transplantation after conditioning with an intensified regimen in patients aged 50 years or more is comparable with that in younger patients.
    Schattenberg A, Schaap N, Preijers F, van der Maazen R, de Witte T.
    Bone Marrow Transplant; 2000 Jul; 26(1):17-22. PubMed ID: 10918401
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J.
    Bone Marrow Transplant; 1993 Jul; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [Abstract] [Full Text] [Related]

  • 3. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
    Carlens S, Ringdén O, Aschan J, Hägglund H, Ljungman P, Mattsson J, Remberger M.
    Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
    [Abstract] [Full Text] [Related]

  • 4. Survival in first or second remission after lymphocyte-depleted transplantation for Philadelphia chromosome-positive CML in first chronic phase.
    Schattenberg A, Preijers F, Mensink E, Bär B, Schaap N, Geurts van Kessel A, van der Maazen R, de Witte T.
    Bone Marrow Transplant; 1997 Jun; 19(12):1205-12. PubMed ID: 9208114
    [Abstract] [Full Text] [Related]

  • 5. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [Abstract] [Full Text] [Related]

  • 6. Outcome of allogeneic bone marrow transplantation with lymphocyte-depleted marrow grafts in adult patients with myelodysplastic syndromes.
    Mattijssen V, Schattenberg A, Schaap N, Preijers F, De Witte T.
    Bone Marrow Transplant; 1997 Apr; 19(8):791-4. PubMed ID: 9134170
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N, Bornhäuser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schäfer-Eckardt K, Beyer J, Kiehl M, Zander AR, German Cooperative Transplant Study Group.
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [Abstract] [Full Text] [Related]

  • 8. Intensification of the conditioning regimen by the addition of anthracyclines results in a higher incidence of sustained molecular remissions after allogeneic bone marrow transplantation for chronic myeloid leukaemia with marrow depleted of lymphocytes by counterflow centrifugation.
    Schattenberg A, Mensink E, de Witte T.
    Cas Lek Cesk; 1996 Apr 17; 135(8):239-43. PubMed ID: 8689662
    [Abstract] [Full Text] [Related]

  • 9. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM, Kusnierz-Glaz C, Valone F, Stockerl-Goldstein KE, Hu WW, Johnston L, Blume KG, Strober S, Negrin RS.
    Cancer; 2001 Jun 15; 91(12):2205-13. PubMed ID: 11413507
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.
    Biol Blood Marrow Transplant; 2008 Jun 15; 14(6):651-7. PubMed ID: 18489990
    [Abstract] [Full Text] [Related]

  • 11. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
    Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M.
    Bone Marrow Transplant; 2004 Oct 15; 34(8):721-7. PubMed ID: 15322568
    [Abstract] [Full Text] [Related]

  • 12. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D, Martino R, Sureda A, Canals C, Altés A, Briones J, Sanz MA, Parody R, Constans M, Villela SL, Brunet S, Sierra J.
    Eur J Haematol; 2005 Feb 15; 74(2):144-51. PubMed ID: 15654906
    [Abstract] [Full Text] [Related]

  • 13. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
    Lee CK, deMagalhaes-Silverman M, Hohl RJ, Hayashi M, Buatti J, Wen BC, Schlueter A, Strauss RG, Gingrich RD.
    Bone Marrow Transplant; 2003 Jan 15; 31(2):121-8. PubMed ID: 12621494
    [Abstract] [Full Text] [Related]

  • 14. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.
    Baker KS, Loberiza FR, Yu H, Cairo MS, Bolwell BJ, Bujan-Boza WA, Camitta BM, Garcia JJ, Ho WG, Liesveld JL, Maharaj D, Marks DI, Schultz KR, Wiernik P, Zander AR, Horowitz MM, Keating A, Weisdorf DJ.
    J Clin Oncol; 2005 Oct 01; 23(28):7032-42. PubMed ID: 16145067
    [Abstract] [Full Text] [Related]

  • 15. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Ball E, Cook D, Andresen S, Kuczkowski E, Bolwell B.
    Bone Marrow Transplant; 2005 Feb 01; 35(3):247-52. PubMed ID: 15580282
    [Abstract] [Full Text] [Related]

  • 16. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.
    Beksac M, Celebi H, Sargín D, Yalcin A, Topcuoglu P, Kalayoglu-Besisik S, Beyan C, Arslan O, Ozcan M, Gurman G, Ilhan O, Akan H.
    Bone Marrow Transplant; 2003 May 01; 31(10):897-904. PubMed ID: 12748666
    [Abstract] [Full Text] [Related]

  • 17. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome.
    Barge RM, Brouwer RE, Beersma MF, Starrenburg CW, Zwinderman AH, Hale G, Waldmann H, den Ottolander GJ, Falkenburg JH, Willemze R, Fibbe WE.
    Bone Marrow Transplant; 2001 May 01; 27(10):1053-8. PubMed ID: 11438820
    [Abstract] [Full Text] [Related]

  • 18. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR.
    Biol Blood Marrow Transplant; 2001 May 01; 7(11):620-30. PubMed ID: 11760150
    [Abstract] [Full Text] [Related]

  • 19. Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM).
    Kröger N, Einsele H, Wolff D, Casper J, Freund M, Derigs G, Wandt H, Schäfer-Eckart K, Wittkowsky G, Schmitz N, Krüger W, Zabelina T, Renges H, Ayuk F, Krüll A, Zander A, German Study-group Multiple Myeloma (DSMM).
    Bone Marrow Transplant; 2003 Jun 01; 31(11):973-9. PubMed ID: 12774047
    [Abstract] [Full Text] [Related]

  • 20. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul 01; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.